IL-17A-producing T cells are associated with the progression of lung adenocarcinoma

Accumulating evidence has shown that T cells are crucial in shaping the tumor microenvironment and regulating tumor development. However, the roles of IL-17A-producing T cells (IL-17A(+)CD4(+)Th17, IL-17A(+)CD8(+) Tc17 and IL-17A(+) gamma delta T17 cells) and related cytokines in the progression of lung cancer (LC) remain uncertain. Here, we found that the frequencies of both Th17 and gamma delta T17 cells in the peripheral blood of patients with lung adenocarcinoma (LA) were higher than those in healthy controls (HCs), whereas the frequency of Tc17 cells in the patients with LA was decreased. In addition, the frequencies of circulating Th17 and gamma delta T17 cells, but not Tc17 cells, were positively associated with tumor invasion and metastasis. Furthermore, the major source of IL-17A production was Th17 cells, followed by Tc17 and gamma delta T17 cells, in peripheral blood from patients with LA and HCs; but the percentages of Th17 and gamma delta T17 cells in total intracellular IL-17A(+) cells obtained from the patients with LC were higher than those from HCs. Moreover, the protein and corresponding mRNA levels of IL-17A, IL-23, IL-1 beta, and TGF-beta 1 were much higher in the patients with LA than those in HCs, and the levels of IL-17A in patients were positively correlated with numbers of both Th17 and gamma delta T17 cells, but not Tc17 cells. Finally, the frequencies of circulating Th17 and gamma delta T17 cells, along with the levels of IL-17A, IL-23, IL-1 beta, and TGF-beta 1 were decreased in the patients with LA after tumor resection, whereas the frequency of circulating Tc17 cells was inversely increased in these patients. Our findings indicate that Th17, Tc17, gamma delta T17 cells, and IL-17A-associated cytokines contribute to the development of LA and thus represent promising targets for therapeutic strategies.